RSSNeurology

Letters to the Editor: Discussing sexual health after traumatic brain injury: an unmet need!

Letters to the Editor: Discussing sexual health after traumatic brain injury: an unmet need!

| February 1, 2017 | 0 Comments

Innov Clin Neurosci. 2017;14(1–2):11–12

Continue Reading

The Right to Die in Chronic Disorders of Consciousness: Can We Avoid the Slippery Slope Argument?

The Right to Die in Chronic Disorders of Consciousness: Can We Avoid the Slippery Slope Argument?

| December 1, 2016 | 0 Comments

by Rocco Salvatore Calabrò, MD, PhD; Antonino Naro, MD, PhD; Rosaria De Luca, MS, PhD; Margherita Russo, MD, PhD; Lory Caccamo, PhD; Alfredo Manuli, MS; Alessia Bramanti; and Placido Bramanti, MD Drs. Calabró, Naro, de Luca, Russo, Manuli, A. Bramanti, and P. Bramanti are from the IRCCS Centro Neurolesi “Bonino-Pulejo” in Messina, Italy; and Dr. […]

Continue Reading

Sympathetic Nerve Entrapment Point Injection as an Antireflux Procedure for Refractory Laryngopharyngeal Reflux: A First Case Report of Innovative Autonomic Regulation

Sympathetic Nerve Entrapment Point Injection as an Antireflux Procedure for Refractory Laryngopharyngeal Reflux: A First Case Report of Innovative Autonomic Regulation

| December 1, 2016 | 0 Comments

by Sangsoo Lee, MD, MSc; Chang Jin Oh, MD; and Jeong Won Seong, MD Dr. Lee is with the Department of Psychiatry at Ahav Hospital, South Korea; Dr. Oh is with the Department of Pain Medicine and Anesthesiology at the Seoul Samsung Union Clinic in South Korea; and Dr. Seong is with the Department of […]

Continue Reading

Editor’s Message: September–October 2016 Issue Highlights

Editor’s Message: September–October 2016 Issue Highlights

| October 9, 2016 | 0 Comments

Dear Colleagues: Welcome to the September-October 2016 issue of Innovations in Clinical Neuroscience (ICNS). As the official journal of the CNS Summit, the International Society for CNS Drug Development (ISCDD), and the International Society for CNS Clinical Trials and Methodology (ISCTM), an important part of our editorial mission is to accelerate and enhance the development […]

Continue Reading

Assessment of Cognitive and Neurologic Recovery in Ischemic Stroke Drug Trials: Results from a Randomized, Double-blind, Placebo-controlled Study

Assessment of Cognitive and Neurologic Recovery in Ischemic Stroke Drug Trials: Results from a Randomized, Double-blind, Placebo-controlled Study

| October 9, 2016 | 0 Comments

by Franco Di Cesare, MD; Jessica Mancuso, PhD; Brian Silver, MD; and Peter T. Loudon, PhD Dr. Di Cesare is with Leoben Research Limited in Glasgow, UK; Dr. Mancuso is with Research Statistics at Pfizer in Groton, Connecticut, USA; Dr. Silver is with Rhode Island Hospital and Alpert Medical School of Brown University in Providence, Rhode […]

Continue Reading

Editor’s Message—Issue Highlights, July–August 2016

Editor’s Message—Issue Highlights, July–August 2016

| August 1, 2016 | 0 Comments

Dear Colleagues: Welcome to the July–August 2016 issue of Innovations in Clinical Neuroscience. We start this issue with an interesting study by MacEwan et al titled, “Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases.” Here, the authors assessed the level of private and public investment in research and development […]

Continue Reading

The Potential Role  of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis

The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis

| August 1, 2016 | 0 Comments

by Nazanin Arjomand Fard, MSci; Gholamreza Azizi, PhD; and Abbas Mirshafiey, PhD Dr. Fard is with Kish International Campus, University of Tehran, Tehran, Iran; Dr. Azizi is with Imam Hassan Mojtaba Hospital, Alborz University of Medical Sciences, Karaj, Iran and Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran; and […]

Continue Reading